Genomic Expression is leveraging it’s clinically applicable sample prep technologies focusing on RNA for Next Generation Sequencing and access to biological samples in a novel partnership model with Rx and Dx companies, which enables the company to create a whole pipeline of Next Generation Diagnost…
Genomic Expression is leveraging it’s clinically applicable sample prep technologies focusing on RNA for Next Generation Sequencing and access to biological samples in a novel partnership model with Rx and Dx companies, which enables the company to create a whole pipeline of Next Generation Diagnostics with limited cash burn, regulatory and payer risk, while maintaining significant product upside.
Genomic Expression’s technology takes the guesswork out of the process of developing personal diagnostics which guide the physician in identifying which drug would be most effective for any given individual patient. The kit and software can be used on any of the instruments already in the labs.
We want to save lives and make healthcare delivery more efficient. Today 90% of drugs are only effective in 30-50% of the population. With global drug sales reaching $825 Billion, an estimated $352 Billion is wasted on ineffective drugs. We can change that AND save lives.
Team (1)
Sectors Genomic Expression Inc serves:
Health Care
Life Sciences
Technology
Join Axial's Private M&A Platform
Genomic Expression Inc connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.